Parenchyma-sparing sleeve resection in advanced nodal disease of NSCLC

J. Schirren, S. Bölükbas (Wiesbaden, Germany)

Source: Annual Congress 2010 - Actual challenges in thoracic surgery
Session: Actual challenges in thoracic surgery
Session type: Oral Presentation
Number: 175
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Schirren, S. Bölükbas (Wiesbaden, Germany). Parenchyma-sparing sleeve resection in advanced nodal disease of NSCLC. Eur Respir J 2010; 36: Suppl. 54, 175

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oligometastatic rib disease resection for cancer patients
Source: Virtual Congress 2021 – Rare thoracic surgical disease and the chest wall
Year: 2021


Sublobar resection for lung cancer
Source: Eur Respir J 2009; 33: 426-435
Year: 2009



Chemoradiotherapy with or without surgical resection for stage III NSCLC
Source: Breathe 2010; 6: 275
Year: 2010

Survival of patients after complete surgical resection in NSCLC stage IV with solitary metastases
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

Chemotherapy plus resection is not better than chemoradiotherapy for baseline unresectable stage IIIA-N2 NSCLC
Source: ISSN=ISSN 1810-6838, ISBN=, page=380
Year: 2007

Resection for metachronous lung cancer after pneumonectomy
Source: Eur Respir J 2005; 26: Suppl. 49, 309s
Year: 2005

Anatomic segmentectomy vs. lobectomy for early stage lung cancer
Source: International Congress 2014 – Current therapeutic options in stage I non-small cell lung cancer (NSCLC)
Year: 2014



Surgical management of early lung cancer: the surgeon's view
Source: Annual Congress 2005 - PG16 - Detection of very early lesions in lung cancer: is this important and should they be treated?
Year: 2005


Safety of bronchoplastic resection after induction therapy for non-small cell lung cancer
Source: Annual Congress 2010 - Risk assessment and prevention of complications in thoracic surgery
Year: 2010

Sublobar resections vs lobectomy for early stage lung cancer: where do we stand?
Source: Virtual Congress 2020 – Lung cancer screening: are we back to the individualised decision-making process?
Year: 2020


Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer
Source: Eur Respir J 2015; 45: 1089-1097
Year: 2015



Prognostic factors and surgical resection of pulmonary metastases from colorectal cancer
Source: International Congress 2019 – General thoracic surgery
Year: 2019

Surgical and survival outcomes of sleeve lobectomy after neoadjuvant theraphy in lung cancer: With group of 265 patients
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021

Early surgical resection for stage I high-grade neuroendocrine caricinoma of lung
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Surgical resection and outcome of multifocal adenocarcinoma of the lung
Source: International Congress 2018 – Pleural effusions, infections and tumours
Year: 2018

Comparison of the new and current TNM staging system in bronchoplastic resection for non-small cell lung cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010


Salvage lung resection for local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011

Survival and postoperative complication after neoadjuvant therapy in resectable stage IIIA-N2 non-small cell lung cancer: a balancing exercise
Source: Eur Respir J 2003; 22: Suppl. 45, 31s
Year: 2003

Is surgical resection of M1a lung adenocarcinoma with metastatic pleural nodules really a useless choice?
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012